1. Home
  2. DFNS vs TXMD Comparison

DFNS vs TXMD Comparison

Compare DFNS & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$0.17

Market Cap

27.2M

ML Signal

N/A

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.11

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFNS
TXMD
Founded
2013
2008
Country
United States
United States
Employees
15
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
24.4M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
DFNS
TXMD
Price
$0.17
$2.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.7M
60.7K
Earning Date
04-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.68
EPS
N/A
0.01
Revenue
N/A
$1,761,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$203.00
Revenue Growth
N/A
35.25
52 Week Low
$0.16
$0.98
52 Week High
$2.68
$2.95

Technical Indicators

Market Signals
Indicator
DFNS
TXMD
Relative Strength Index (RSI) 28.42 51.81
Support Level N/A $1.90
Resistance Level $0.51 $2.16
Average True Range (ATR) 0.03 0.16
MACD 0.00 0.00
Stochastic Oscillator 6.06 45.16

Price Performance

Historical Comparison
DFNS
TXMD

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Share on Social Networks: